Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Astellas_Pharma
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:focus |
regenerative medicine
|
| gptkbp:foundedYear |
1994
|
| gptkbp:fullName |
Advanced Cell Technology, Inc.
|
| gptkbp:headquartersLocation |
gptkb:Marlborough,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
ACTC
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableContributor |
stem cell therapy
|
| gptkbp:status |
acquired
|
| gptkbp:stockSymbol |
gptkb:ACTC
|
| gptkbp:website |
http://www.advancedcell.com/
|
| gptkbp:bfsParent |
gptkb:All_Ceylon_Tamil_Congress
gptkb:Associated_Colleges_of_the_Twin_Cities |
| gptkbp:bfsLayer |
7
|